Skip to main content

Advertisement

SpringerLink
Log in

Autoimmune hepatitis

Definition — classification — histopathology — immunopathogenesis

  • Review Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

Autoimmune hepatitis (AIH) is a distinct form of acute and chronic inflammatory liver disease in which immune reactions against host antigens are found to be the major pathological mechanism. If left untreated it carries an unfavourable prognosis, and the diagnosis should be made as soon as possible. The diagnostic approach has been greatly facilitated by the establishment of a panel of marker autoantibodies, which do not define distinct therapeutic groups of AIH, but do allow a subgrouping based on differences in patient populations, some clinical features and prognosis. The characterization of organ-specific components of the liver cell surface as targets of cellular and humoral autoimmune reactions give new insights into the pathogenesis of the disease, even though the primary event triggering the disease remains to be defined. The most important diseasepromoting factor seems to be a genetically determined background for autoimmunity. Without this different environmental factors, including viruses, toxins, cytokines and drugs, are only able to induce transient autoimmune phenomena and not autoimmune disease. The histopathology of AIH is in keeping with the present pathogenetic concept. Although there is no pathognomonic feature distinguishing this type of hepatitis from virus-induced forms, some distinct morphological lesions are regarded as characteristic. Clinical research on AIH has benefited greatly from observations of experimental AIH in mice. Recognition of the critical role of autoreactive T-lymphocytes in the pathogenesis and the observation of spontaneous recovery from AIH in the animal model associated with antigen-specific and antigen-non-specific T-cell suppression have made basic contributions to our improved understanding of the natural course of AIH in humans.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aiza I, Chiff ER (1995) Autoimmune hepatitis. Curr Opin Gastroenterol 11: 238–244

    Google Scholar 

  2. Autschbach F, Meuer SC, Moebius U, Manns M, Hess G, Meyer zum Büschenfelde K-H, Thoenes W, Dienes H-P (1991) Hepatocellular expression of lymphocyte function-associated antigen 3 in chronic hepatitis. Hepatology 14: 223–230

    Google Scholar 

  3. Bach N, Thung SN, Schaffner F (1992) The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 15: 572–577

    Google Scholar 

  4. Bearn AG, Kunkel HG, Slater RJ (1956) The problem of chronic liver disease in young women. Am J Med 21: 3–15

    Google Scholar 

  5. Beaune PH, Dansette PM, Mansuy D, et al (1987) Human endoplasmatic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P450 that hydroxylates the drug. Proc Natl Acad Sci USA 551–555

  6. Bernuau D, Rogier E, Feldmann G (1982) A quantitative ultrastructural analysis of the leukocytes in contrast with hepatocytes in chronic active hepatitis with a cytochemical detection of mononuclear phagocytes. Am J Pathol 109: 310–320

    Google Scholar 

  7. Campston DAS, Vincent A, Newsom Davis J, Batchelor JR (1980) Clinical, pathological, HLA-antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain 103: 579–601

    Google Scholar 

  8. Chapman PB, Lester TJ, Casper ES, Gabrilove JL, Wong GY, Kempin SJ, Gold PJ, Welt S, Warren RS, Fletcher Starnes H, Sherwin SA, Old LJ, Oettgen HF (1987) Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer. J Clin Oncol 5: 1942–1951

    Google Scholar 

  9. Cohen IR, Miller A (1994) Autoimmune disease models. Academic Press, New York London

    Google Scholar 

  10. Czaja AJ, Manns MP, Homburger HA (1992) Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology 103: 1290–1295

    CAS  PubMed  Google Scholar 

  11. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB (1993) Genetic predispositions for the immunological features of chronic active hepatitis. Hepatology 18: 816–822

    Google Scholar 

  12. Dienes HP (1988) Viral and autoimmune hepatitis. Fischer, Stuttgart New York

    Google Scholar 

  13. Dienes HP (1995) Die autoimmune Hepatitis. Verh Dtsch Ges Pathol 79: 177–185

    Google Scholar 

  14. Dienes HP, Popper H, Manns M, et al (1989) Histologic features in autoimmune hepatitis. Z. Gastroenterol 27: 325–330

    Google Scholar 

  15. Dienes HP, Autschbach F, Gerber MA (1991) Ultrastructural lesion in autoimmune hepatitis and steps of the immune response in liver tissue. Semin Liv Dis 11: 197–203

    Google Scholar 

  16. Doherty DG, Donaldson PT, Underhill GA, Farrant JM, Duthi A, Mieli-Vergani G, McFarlane IG (1994) Allelic sequence variation in the class II genes and proteins in patients with autoimmune hepatitis. Hepatology 19: 609–615

    Google Scholar 

  17. Donaldson PT, Doherty DG, Underhill GA, Williams R (1994) The molecular genetic of autoimmune liver disease. Hepatology 20: 225–239

    Google Scholar 

  18. Eggink HF, Houthoff HJ, Huitema S, Gips C, Poppema S (1982) Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets and viral antigens in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B, and primary biliary cirrhosis. Clin Exp Immunol 50: 17–21

    Google Scholar 

  19. Franco A, Barnaba V, Kuberti G, et al (1990) Liver-derived T cell clones in autoimmune chronic active hepatitis: accessory function of hepatocytes expressing class II major histocompatibility molecules. Clin Immunol Immunopathol 54: 382–394

    Google Scholar 

  20. Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G (1995) Concanavalin A-induced T cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 21: 190–198

    Google Scholar 

  21. Garcia-Buey L, Garcia-Monzon C, Rodriguez S, et al (1995) Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterology 108: 1770–1777

    Google Scholar 

  22. Good RA (1956) Plasma cell hepatitis and extreme hyperglobulinemia in adolescent females. Am J Dis Child 92: 508–509

    Google Scholar 

  23. Hodges JR, Millward-Sadler GH, Wright R (1982) Chronic active hepatitis: the spectrum of disease. Lancet I: 550–552

    Google Scholar 

  24. Homberg JC, Andre C, Abuaf N (1984) A new anti liver/kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis. Clin Exp Immunol 55: 561–570

    Google Scholar 

  25. Homberg JC, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil SH, Poupon R, Darins F, Levy VG, Grippon P, Opolon P, Bernuau J, Benhamou JP, Algille D (1987) Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of autoimmune hepatitis. Hepatology 7: 1333–1339

    Google Scholar 

  26. Hopf U, Meyer zum Büschenfelde KH (1974) Studies on the pathogenesis of experimental chronic hepatitis in rabbits. II. Demonstration of immunoglobulin on isolated hepatocytes. Br J Exp Pathol 55: 509–513

    Google Scholar 

  27. Hopf U, Arnold W, Meyer zum Büschenfelde KH, et al (1975) Studies on the pathogenesis of chronic inflammatory liver diseases. I. Membrane-fixed IgG on isolated hepatocytes from patients. Clin Exp Immunol 22: 1–8

    Google Scholar 

  28. Hopf U, Meyer zum Büschenfelde KH, Arnold W (1976) Detection of a liver membrane autoantibody in HBsAg-negative chronic hepatitis. N Engl J Med 294: 587–582

    Google Scholar 

  29. Hopf U, Jahn HU, Möller B, et al (1990) Liver membrane antibodies (LMA) recognize a 26-kD protein on the hepatocellular surface. Clin Exp Immunol 79: 54–61

    Google Scholar 

  30. Huppertz HI, Treichel U, Gassel AM, et al (1995) Autoimmune hepatitis following hepatitis A virus infection. J Hepatol 23: 204–208

    Google Scholar 

  31. Hussain MJ, Mowat AP, Miele-Vergani G, Vergani D (1990) Circulating levels of interleucin-1α, tumor necrosis factor, interferon-γ and soluble interleucin-2 receptor are high in children with autoimmune chronic liver disease. Hepatology 12: 937

    Google Scholar 

  32. Inoko H, Kiyosawa K (1992) HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. Gastroenterology 103: 1041–1047

    Google Scholar 

  33. Jensen DM, McFarlane IG, Portmann BS, Eddleston ALWF, Williams R (1978) Detection of antibodies directed against liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis. N Engl J Med 299: 1–7

    Google Scholar 

  34. Johnsohn PJ, McFarlane IG (1993) Meeting report: International Autoimmune Hepatitis Group. Hepatology 18: 998–1005

    Google Scholar 

  35. Johnson GD, Holborow EJ, Glynn LE (1965) Antibody to smooth muscle in patients with liver disease. Lancet II: 878–879

    Google Scholar 

  36. Joske RA, King WE (1955) The L.E. cell phenomenon in active chronic viral hepatitis. Lancet II: 477–480

    Google Scholar 

  37. Kakumu S, Arakawa Y, Goyi H, et al (1979) Occurrence and significance of antibody to liver-specific membrane lipoprotein by double-antibody immunoprecipitation method in sera of patients with acute and chronic liver diseases. Gastroenterology 76: 665–671

    Google Scholar 

  38. Kenny RP, Czaja AJ, Ludwig J, Dickson ER (1986) Frequency and significance of anti-mitochondrial antibodies in severe chronic active hepatitis. Dig Dis Sci 31: 705–711

    Google Scholar 

  39. Kirk AP, Jain S, Pocock S, Thomas HC, Sherlock S (1980) Late results of the Royal Free Hospital prospective controlled trial in hepatitis B surface antigen negative chronic active hepatitis. Gut 21: 78–83

    Google Scholar 

  40. Kössling FK, Meyer zum Büschenfelde KH (1968) Zur Induktion einer aktiven chronischen Hepatitis durch heterologe Leberproteine. Virchows Arch [A] 345: 365–376

    Google Scholar 

  41. Kudo M, Todo A, Ikekubo K, et al (1987) Evaluation of asialoglycoprotein receptor-binding, synthetic radiolabeled glycoprotein in estimating hepatic functional reserve. Acta Hepatol Jap 28: 1277–1286

    Google Scholar 

  42. Kunkel HG, Ahrens JR, Eisenmenger WJ, Bongiovanni AM, Slater RJ (1951) Extreme hypergammaglobulinemia in young women with liver disease of unknown etiology. J Clin Invest 30: 654

    Google Scholar 

  43. Laskus T, Slusarczyk J (1989) Autoimmune chronic active hepatitis developing after acute type B hepatitis. Dig Dis Sci 34: 1294–1297

    Google Scholar 

  44. Lefkowitch JH, Apfelbaum TF, Weinberg L (1984) Acute liver biopsy lesions in early autoimmune (lupoid) chronic active hepatitis. Liver 4: 379–386

    Google Scholar 

  45. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, Wendel A (1995) Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 146: 5

    Google Scholar 

  46. Leist M, Gantner F, Jilg S, Wendel A (1995) Activation of the 55 kDa TNF Receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol 154: 1307–1316

    Google Scholar 

  47. Lenzi M, Johnson PJ, McFarlane IG, Ballardini G, Smigh HM, McFarlane BM, Bridger C, Vergani D, Bianchi FB, Williams R (1991) Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet 338: 277–280

    Google Scholar 

  48. Löhr H, Treichel U, Poralla T, Manns M, Meyer zum Büschenfelde KH, Fleischer B (1990) The human hepatic asialoglycoprotein receptor is a target antigen for liver-infiltrating T cells in autoimmune chronic active hepatitis and primary biliary cirrhosis. Hepatology 12: 1314–1320

    Google Scholar 

  49. Löhr H, Manns M, Kyriatsoulis A, Lohse AW, Trautwein C, Meyer zum Büschenfelde KH, Fleischer B (1991) Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis. Clin Exp Immunol 84: 297–302

    Google Scholar 

  50. Löhr H, Treichel U, Poralla T, Manns M, Meyer zum Büschenfelde KH, Fleischer B (1992) Liver-infiltrating T helper cells in autoimmune chronic active hepatitis stimulate the production of autoantibodies against the human asialoglycoproteinreceptor in vitro. Clin Exp Immunol 88: 45–49

    Google Scholar 

  51. Löhr H, Schlaak JF, Gerken G, Fleischer B, Dienes H-P, Meyer zum Büschenfelde KH (1994) Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver 14: 161–166

    Google Scholar 

  52. Löhr HF, Gerken G, Michel G, Braun HB, Meyer zum Büschenfelde KH (1994) In vitro secretion of anti-GOR protein and anti-hepatitis C virus antibodies in patients with chronic hepatitis C. Gastroenterology 107: 1443–1448

    Google Scholar 

  53. Loeper J, Descatoire V, Maurice M, Beaune P, Feldmann G, Larrey O, Pessayre D (1990) Presence of functional cytochrome P450 on isolated rat hepatocyte plasma membrane. Hepatology 11: 145–153

    Google Scholar 

  54. Lohse AW (1991) Experimental models of autoimmune hepatitis. Semin Liver Dis 11: 241–247

    Google Scholar 

  55. Lohse AW, Meyer zum Büschenfelde KH (1993) Remission of experimental autoimmune hepatitis is associated with antigen-specific and non-specific immunosuppression. Clin Exp Immunol 94: 163–167

    Google Scholar 

  56. Lohse AW, Manns M, Dienes HP, Meyer zum Büschenfelde KH, Cohen IR (1990) Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity. Hepatology 11: 24–30

    Google Scholar 

  57. Lohse AW, Gerken G, Mohr H, Löhr HF, Treichel U, Dienes HP, Meyer zum Büschenfelde KH (1995) Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients. Ger J Gastroenterol 33: 527–533

    Google Scholar 

  58. Lohse AW, Kögel M, Meyer zum Büschenfelde KH (1995) Evidence for spontaneous immunosuppression in autoimmune hepatitis. Hepatology 22: 381–388

    Google Scholar 

  59. Mackay IR, Morris PJ (1972) Association of autoimmune chronic active hepatitis with HLA-A1, A2, B8. Lancet II: 793–795

    Google Scholar 

  60. Mackay IR, Taft LI, Cowling DC (1956) Lupoid hepatitis. Lancet II: 1323–1326

    Google Scholar 

  61. Manns MP (1991) Cytoplasmic Autoantigens in autoimmune hepatitis: molecular analysis and clinical relevance. Semin Liver Dis 11: 205–214

    Google Scholar 

  62. Manns MP, Krüger M (1994) Immunogenetics of chronic liver diseases. Gastoenterology 106: 1676–1697

    Google Scholar 

  63. Manns M, Meyer zum Büschenfelde KH, Hess G (1980) Autoantibodies against liver specific protein: studies on disease-, species- and organ-specificity. Gut 21: 995–961

    Google Scholar 

  64. Manns M, Gerken G, Kyriatsoules A, Staritz M, Meyer zum Büschenfelde KH (1987) Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet 1: 292–294

    Google Scholar 

  65. Manns MP, Johnson EF, Griffen KJ, Tan EM, Sullivan KF (1989) Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450 db. J Clin Invest 83: 1066–1072

    Google Scholar 

  66. Martini E, Nisen A, Cavalli F, et al (1988) Antibodies to liver cytosol (Anti LC1) in patients with autoimmune chronic active hepatitis. Hepatology 8: 1662–1666

    Google Scholar 

  67. Mayet WJ, Hess G, Gerken G, Rossol S, Voth R, Manns M, Meyer zum Büschenfelde KH (1989) Treatment of chronic type B hepatitis with recombinant alpha interferon induces autoantibodies not specific for autoimmune chronic hepatitis. Hepatology 10: 24–28

    Google Scholar 

  68. McFarlane BM, McSorley CG, Vergani D, McFarlane IG, Williams R (1986) Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders. J Hepatol 3: 196–205

    Google Scholar 

  69. McFarlane BM, Sipos J, Gove CD, et al (1990) Antibodies against the hepatic asialoglycoprotein receptor perfused in situ preferentially attach to periportal liver cells in the rat. Hepatology 11: 408–415

    Google Scholar 

  70. McFarlane IG (1991) Autoimmunity and hepatotropic viruses. Semin Liver Dis 11: 221–233

    Google Scholar 

  71. McFarlane IG, McFarlane BM, Major GN, Tolley P, Williams R (1984) Identification of the hepatic asialoglycoprotein receptor (hepatic lectin) as a component of liver specific membrane lipoprotein (LSP). Clin Exp Immunol 55: 347–354

    Google Scholar 

  72. McFarlane IG, Hegarty JE, Mc Sorley CG, McFarlane BM, Williams R (1984) Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis. Lancet II: 954–956

    Google Scholar 

  73. Meyer zum Büschenfelde KH, Hopf U (1974) Studies on the pathogenesis of experimental chronic hepatitis in rabbits. I. Induction of the disease and protective effect of allogenic liver specific protein. Br J Exp Pathol 55: 498–508

    Google Scholar 

  74. Meyer zum Büschenfelde KH, Lohse AW (1995) Autoimmune hepatitis. N Engl J Med 333: 1084–1085

    Google Scholar 

  75. Meyer zum Büschenfelde KH, Miescher PA (1972) Liver-specific antigens, purification and characterization. Clin Exp Immunol 10: 89–102

    Google Scholar 

  76. Meyer zum Büschenfelde KH, Schrank CH (1966) Untersuchungen zur Frage organspezifischer Antigene der Leber. Klinische Wochenschr 44: 654–656

    Google Scholar 

  77. Meyer zum Büschenfelde KH, Kössling FK, Miescher PA (1972) Experimental chronic active hepatitis in rabbits following immunization with human liver proteins. Clin Exp Immunol 10: 99–108

    Google Scholar 

  78. Meyer zum Büschenfelde KH, Knolle J, Berger J (1974) Celluläre Immunreaktionen gegenüber homologen leberspezifischen Antigenen (HLP) bei chronischen Leberentzündungen. Klin Wochenschr 52: 246–248

    Google Scholar 

  79. Meyer zum Büschenfelde KH, Manns M, Hütteroth T, et al (1979) LM-Ag and LSP — two different target antigens involved in the immunopathogenesis of chronic active hepatitis? Clin Exp Immunol 37: 205–212

    Google Scholar 

  80. Meyer zum Büschenfelde KH, Lohse AW, Manns M, Poralla T (1990) Autoimmunity and liver disease. Hepatology 12: 354–363

    Google Scholar 

  81. Michel G, Ritter A, Gerken G, Meyer zum Büschenfelde KH, Decker R, Manns MP (1992) Anti-GOR and hepatitis C virus in autoimmune liver diseases. Lancet 339: 267–269

    Google Scholar 

  82. Mieli-Vergani G, Vergani D, Jenkins PJ, et al (1979) Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis. Clin Exp Immunol 38: 16–21

    Google Scholar 

  83. Mitchel LS, Jeffers LJ, Reddy KR, Cheinquer H, Coelho-Little E, Moreda R, Parker T, Silva M, Li XM, de Medina M, Coelho-Borges S, Hill M, Altmann R, Manns P, Schiff ER (1993) Detection of hepatitis C virus antibody by first and second generation assays and polymerase chain reaction in patients with autoimmune chronic active hepatitis types, I, II and II. Am J Gastroenterol 88: 1027–1034

    Google Scholar 

  84. Nakanuma Y, Harada K, Nonomura A, Matsushita E, Unoura M (1994) Pathology of autoimmune hepatitis and related diseases. In: Nishioka M, Toda G, Zeniya M (eds) Autoimmune hepatitis. Elsevier, Amsterdam, p 85

    Google Scholar 

  85. Newson-Davis J, Harcourt G, Sommer N, et al (1989) T-cell reactivity in myasthenia gravis. J Autoimmun 2: 101–108

    Google Scholar 

  86. O'Brien CJ, Vento S, Donaldson PT, et al (1986) Cell-mediated immunity and suppressor-T-cell defect to liver derived antigens in families of patients with autoimmune chronic active hepatitis. Lancet I: 350–353

    Google Scholar 

  87. Page AR, Good RA (1962) Plasma cell hepatitis. Lab Invest 11: 351–359

    Google Scholar 

  88. Paulson JC, Weinstein J, Schauer A (1989) Tissue-specific expression of sialyltransferases. J Biol Chem 264: 10931–10933

    Google Scholar 

  89. Philipp J, Durrazo M, Trautwein CH, Alex B, Straub P, Laub JG, Johnson EF, Tukey RH, Manns MP (1994) Recognition of uridine diphosphate glucuronosyl transferase by LKM3 antibodies in chronic hepatitis D. Lancet 344: 578–581

    Google Scholar 

  90. Poralla T, Ramadori G, Dienes H, et al (1987) Liver cell damage caused by monoclonal antibody against an organ-specific membrane antigen in vivo and in vitro. J Hepatol 4: 373–380

    Google Scholar 

  91. Poralla T, Treichel U, Löhr H, Fleischer B (1991) The asialoglycoprotein receptor as target structure in autoimmune liver diseases. Semin Liver Dis 11: 215–222

    Google Scholar 

  92. Rahaman SM, Chira P, Koff RS (1994) Idiopathic autoimmune chronic hepatitis triggered by hepatitis A. Am J Gastroenterol 89: 106–109

    Google Scholar 

  93. Rizzeto M, Swana G, Doniach D (1973) Microsomal antibodies in active chronic hepatitis and other disorders. Clin Exp Immunol 15: 331–334

    Google Scholar 

  94. Robertson DA, Zhang SL, Guy EC (1987) Persistent measles virus genome in autoimmune chronic active hepatitis. Lancet II: 9–11

    Google Scholar 

  95. Robin MA, Maratrat M, Loeper J, et al (1995) Cytochrome P4502B follows a vesicular route to the plasma membrane in cultured rat hepatocytes. Gastroenterology 108: 1110–1123

    Google Scholar 

  96. Rosenberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S, Marston Linehan W, Robertson CN, Lee RE, Rubin JT, Seipp CA, Simpson CG, White DE (1987) A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 316: 889–897

    CAS  PubMed  Google Scholar 

  97. Sawamura T, Nakada H, Hazama H, et al (1984) Hyperasialoglycoproteinemia in patients with chronic liver diseases and liver cell carcinoma. Gastroenterology 87: 1217–1221

    Google Scholar 

  98. Scheuer PJ (1987) Viral hepatitis. In: MacSween RNM, Anthony PP, Scheuer PJ (eds) Pathology of the liver. Churchill Livingstone, Edinburgh, pp 202–203

    Google Scholar 

  99. Scheuer PJ (1988) Liver biopsy interpretation, 4th edn. Baillière-Tindall, London

    Google Scholar 

  100. Schlaak JF, Löhr H, Gallati H, Meyer zum Büschenfelde KH, Fleischer B (1993) Analysis of the in vitro cytokine production by liver-infiltrating T cells of patients with autoimmune hepatitis. Clin Exp Immunol 94: 168–173

    Google Scholar 

  101. Seki T, Kiyosawa K, Inoko H, Ota M (1990) Association of auto-immune hepatitis with HLA-Bw 54 and DR4 in Japanese patients. Hepatology 12: 1300–1304

    Google Scholar 

  102. Sherlock S (1989) Chronic autoimmune lupoid hepatitis. In: Sherlock S (ed) Diseases of the liver and biliary system, 8th edn. Blackwell, Oxford, pp 348–356

    Google Scholar 

  103. Stockert RJ, Morell AG, Ashwell G (1991) Structural characteristics and regulation of the asialoglycoprotein receptor. In: Wu GY, Wu CH (eds) Liver diseases: targeted diagnosis and therapy using specific receptors and ligands. Dekker, New York, pp 41–64

    Google Scholar 

  104. Swanson NR, Reed WD, Yarred LJ, Shilkin KB, Joske RA (1990) Autoantibodies to isolated plasma membranes in chronic active hepatitis. II. Specificity of antibodies. Hepatology 11: 613–621

    Google Scholar 

  105. Tiegs G, Hentschel J, Wendel A (1992) A T cell-dependent experimental liver injury in mice inducible by concanavalin. Am J Clin Invest 90: 196–203

    Google Scholar 

  106. Treichel U, Gerken G, Rossol S, Rotthauwe HW, Meyer zum Büschenfelde KH, Poralla T (1993) Autoantibodies against the human asialoglycoprotein receptor: effects of therapy in autoimmune and virus-induced chronic active hepatitis. J Hepatol 19: 55–63

    Google Scholar 

  107. Treichel U, McFarlane BM, Takeshi S, Krawitt EL, Alessi N, Stickel F, McFarlane IG, Kendo K, Seichi F, Freni MA, Gerken G, Meyer zum Büschenfelde KH (1994) Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis. Gastroenterology 107: 799–804

    Google Scholar 

  108. Treichel U, Paietta E, Poralla T, Meyer zum Büschenfelde KH, Stockert RJ (1994) Effects of cytokines on synthesis and function of the hepatic asialoglycoprotein receptor. J Cell Physiol 158: 527–534

    Google Scholar 

  109. Treichel U, Meyer zum Büschenfelde KH, Gerken G (1995) Hepatitis C virus infection and autoimmunity: clinical features, diagnostic tools and therapeutical aspects. Méd Mal Infect 25 (Spécial): 1089–1096

    Google Scholar 

  110. Treichel U, Schreiter T, Tassopoulous N, et al (1996) Zur Bedeutung des Nachweises zirkulierender Autoantikörper bei 257 Patienten mit akuter Hepatitis. Z Gastroenterol (in press)

  111. Vento S, Di Perri G, Garofano T, et al (1990) Hazards of interferon therapy for HBV-negative chronic hepatitis. Lancet II: 926

    Google Scholar 

  112. Volpes R, Van den Oord JJ, Desmet VJ (1992) Vascular adhesion molecules in acute and chronic liver inflammation. Hepatology 15: 269–275

    Google Scholar 

  113. Waldenström J (1950) Leber, Blutproteine und Nahrungseiweiss. 8. Tagung Stoffwechsel-Krh., Bad Kissingen, Sonderband XV: 113–119

    Google Scholar 

  114. Wandl UB, Kloke O, Niederle N (1992) Liver failure due to recombinant alpha inteferon for chronic myelogenous leukemia. Lancet I: 123–124

    Google Scholar 

  115. Weiss P, Ashwell G (1989) Ligand-induced modulation of the hepatic receptor for asialoglycoproteins. Evidence for the role of cell surface hyposialylation. J Biol Chem 264: 11572–11574

    Google Scholar 

  116. Wen L, Peakman M, Lobo-Yeo A, McFarlane BM, Mowat A, Mieli-Vergani G, Vergani D (1990) T-cell-directed hepatocyte damage in autoimmune chronic active hepatitis. Lancet 336: 1527–1530

    Google Scholar 

  117. Yonekura T, Kuroda H, Tajima J (1989) Ultrastructural study of interlobular bile ductural disorganization in autoimmune liver diseases. Jpn J Gastroenterol 86: 1638–1644

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. First Department of Internal Medicine, Johannes Gutenberg University Mainz, Langenbeckstrasse 1, D-55101, Mainz, Germany

    Karl-Hermann Meyer zum Büschenfelde

  2. Department of Pathology, Johannes Gutenberg University, Langenbeckstrasse 1, D-55101, Mainz, Germany

    Hans-Peter Dienes

Authors
  1. Karl-Hermann Meyer zum Büschenfelde
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hans-Peter Dienes
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This article is dedicated to Prof. Dr. Dr. h.c. Paul Schölmerich on the occasion of his 80th birthday

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meyer zum Büschenfelde, KH., Dienes, HP. Autoimmune hepatitis. Vichows Archiv A Pathol Anat 429, 1–12 (1996). https://doi.org/10.1007/BF00196814

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00196814

Key words

Search

Navigation